p38 MAPK and MKP-1 control the glycolytic program via the bifunctional glycolysis regulator PFKFB3 during sepsis

J Biol Chem. 2023 Apr;299(4):103043. doi: 10.1016/j.jbc.2023.103043. Epub 2023 Feb 17.

Abstract

Hyperlactatemia often occurs in critically ill patients during severe sepsis/septic shock and is a powerful predictor of mortality. Lactate is the end product of glycolysis. While hypoxia due to inadequate oxygen delivery may result in anaerobic glycolysis, sepsis also enhances glycolysis under hyperdynamic circulation with adequate oxygen delivery. However, the molecular mechanisms involved are not fully understood. Mitogen-activated protein kinase (MAPK) families regulate many aspects of the immune response during microbial infections. MAPK phosphatase (MKP)-1 serves as a feedback control mechanism for p38 and JNK MAPK activities via dephosphorylation. Here, we found that mice deficient in Mkp-1 exhibited substantially enhanced expression and phosphorylation of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase (PFKFB) 3, a key enzyme that regulates glycolysis following systemic Escherichia coli infection. Enhanced PFKFB3 expression was observed in a variety of tissues and cell types, including hepatocytes, macrophages, and epithelial cells. In bone marrow-derived macrophages, Pfkfb3 was robustly induced by both E. coli and lipopolysaccharide, and Mkp-1 deficiency enhanced PFKFB3 expression with no effect on Pfkfb3 mRNA stability. PFKFB3 induction was correlated with lactate production in both WT and Mkp-1-/- bone marrow-derived macrophage following lipopolysaccharide stimulation. Furthermore, we determined that a PFKFB3 inhibitor markedly attenuated lactate production, highlighting the critical role of PFKFB3 in the glycolysis program. Finally, pharmacological inhibition of p38 MAPK, but not JNK, substantially attenuated PFKFB3 expression and lactate production. Taken together, our studies suggest a critical role of p38 MAPK and MKP-1 in the regulation of glycolysis during sepsis.

Keywords: c-Jun N-terminal kinase; dual-specificity phosphoprotein phosphatase; glycolysis; infection; p38 MAPK; sepsis.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Dual Specificity Phosphatase 1* / genetics
  • Dual Specificity Phosphatase 1* / metabolism
  • Escherichia coli / metabolism
  • Glycolysis*
  • Lactates
  • Lipopolysaccharides
  • Mice
  • Oxygen
  • Phosphofructokinase-2 / metabolism
  • Protein Tyrosine Phosphatases / metabolism
  • Sepsis* / genetics
  • p38 Mitogen-Activated Protein Kinases* / metabolism

Substances

  • Dual Specificity Phosphatase 1
  • Lactates
  • Lipopolysaccharides
  • Oxygen
  • p38 Mitogen-Activated Protein Kinases
  • Protein Tyrosine Phosphatases
  • Dusp1 protein, mouse
  • PFKFB3 protein, mouse
  • Phosphofructokinase-2